Odonate Therapeutics, Inc. (ODT) Social Stream

Featured Post From StockTwits About ODT

$ODT New Press Release:

SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to Investors

Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: ODT) relating to possible false statements to investors regarding its only product, tesetaxel, a drug the company was formerly developing for the treatment of breast cancer. A securities class action in the U.S. District Court for the Southern District of California recently survived a motion to dismiss allegations that between December 7, 2017 and March 19 (...)

https://wchr.one/112070